股票 › ABUS
阿布图斯生物制药 ABUS
美股市值排名 #3432
$3.66 −$0.02 (-0.41%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.65 -0.14%
开盘$3.65
昨收$3.67
当日区间$3.62 – $3.75
成交量1.72M
市值$724.08M
市盈率（TTM）4.6
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例82.1%-8.99 个百分点，较上季度
持仓机构数214+11 ，较上季度
内部人近期交易29次买入 / 21次卖出净买入
空头持仓比例12.40% 占流通股回补天数 4.3 · 截至 15 Oct 2026
卖空成交量占比23.0%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$2.66M（10个净流入日，10个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有43.1%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从10.24%升至12.40%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +686,834 | 0.3% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +620,717 | 0.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +565,661 | 7.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +278,951 | 0.1% |
| Nomura Holdings, Inc. | Public Company | 2026/Q3 | +1,637,081 | 0.8% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +1,602,576 | 0.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,526,669 | 4.0% |
| Bank of America Corporation | Public Company | 2026/Q3 | +962,569 | 1.3% |
| Rubric Capital Management LP | Hedge Fund | 2026/Q3 | +906,548 | 3.8% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +803,792 | 0.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +799,125 | 7.0% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +650,700 | 0.3% |
| Mackenzie Financial Corporation | Mutual Fund | 2026/Q3 | +613,806 | 0.3% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +555,488 | 0.3% |
| Two Seas Capital LP | Hedge Fund | 2026/Q3 | +538,040 | 9.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | Robert Beardsley | Independent Director | Sale to Issuer | -17,948 | $5.00 | 14,328 |
| 30 Sep 2026 | Roger Sawhney | Independent Director | Sale to Issuer | -17,142 | $5.00 | 13,683 |
| 30 Sep 2026 | Roivant Sciences Ltd. | Sale to Issuer | -8,967,383 | $5.00 | 29,880,079 | |
| 30 Sep 2026 | Lindsay Androski | Chairperson & CEO | Sale to Issuer | -24,655 | $5.00 | 47,682 |
| 30 Sep 2026 | Tuan Nguyen | Chief Financial Officer | Sale to Issuer | -48,081 | $5.00 | 111,882 |
| 17 Sep 2026 | Robert Beardsley | Independent Director | Derivative Exercise and Sale | -99,057 | $5.07 | 32,276 |
| 17 Sep 2026 | Robert Beardsley | Independent Director | Derivative Exercise and Retained | +32,276 | $3.20 | 32,276 |
| 17 Sep 2026 | Roger Sawhney | Independent Director | Derivative Exercise and Sale | -100,508 | $5.07 | 30,825 |
| 17 Sep 2026 | Roger Sawhney | Independent Director | Derivative Exercise and Retained | +30,825 | $3.34 | 30,825 |
| 17 Sep 2026 | Lindsay Androski | Chairperson & CEO | Derivative Exercise and Sale | -82,527 | $5.07 | 72,337 |
| 17 Sep 2026 | Lindsay Androski | Chairperson & CEO | Derivative Exercise and Retained | +44,337 | $3.20 | 72,337 |
| 17 Sep 2026 | Tuan Nguyen | Chief Financial Officer | Derivative Exercise and Sale | -206,637 | $5.07 | 159,963 |
| 17 Sep 2026 | Tuan Nguyen | Chief Financial Officer | Derivative Exercise and Retained | +86,463 | $3.49 | 159,963 |
| 7 Jun 2026 | Robert Beardsley | Independent Director | Other Derivative Acquisition | +78,800 | $4.24 | 78,800 |
| 7 Jun 2026 | Roger Sawhney | Independent Director | Other Derivative Acquisition | +78,800 | $4.24 | 78,800 |
| 1 Feb 2026 | Lindsay Androski | Chairperson & CEO | Other Acquisition | +28,000 | – | 28,000 |
| 1 Feb 2026 | Lindsay Androski | Chairperson & CEO | Other Derivative Acquisition | +71,700 | $4.39 | 71,700 |
| 1 Feb 2026 | Tuan Nguyen | Chief Financial Officer | Other Acquisition | +73,500 | – | 73,500 |
| 1 Feb 2026 | Tuan Nguyen | Chief Financial Officer | Other Derivative Acquisition | +188,400 | $4.39 | 188,400 |
| 3 Aug 2025 | Roger Sawhney | Independent Director | Other Derivative Acquisition | +157,600 | $3.34 | 157,600 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 24,566,591 | 12.4% | 4.3 |
| 30 Sep 2026 | 34,053,358 | 17.2% | 3.5 |
| 15 Sep 2026 | 18,484,910 | 9.3% | 5.0 |
| 31 Aug 2026 | 18,916,119 | 9.5% | 3.1 |
| 14 Aug 2026 | 18,456,085 | 9.3% | 15.1 |
| 31 Jul 2026 | 20,236,241 | 10.2% | 13.7 |
暂无评论——快来第一个聊聊 ABUS。
登录后参与讨论。